Direxion Daily Financial Bull 3X Shares ETF
FAS
Ultra Financials Proshares
UYG
iShares Biotechnology ETF
IBB
4
Spdr S&P Insurance Etf
KIE
5
Financial Select Sector SPDR Fund
XLF
No Data
Actinogen Boosts Director Equity With New Employee Share Plan Issue
Actinogen Medical Seeks ASX Quotation for 56 Million New Shares
Actinogen Shareholders Back All Resolutions as Xanamem Trials Advance
Actinogen Medical Receives Independent DMC Positive Recommendation for Phase 2b/3 Alzheimer's Disease Trial, Shares Jump 10%
Actinogen Clears Third Safety Review in Pivotal Alzheimer's Trial
Actinogen Medical Reaches Common Understanding With European Regulator on Pathway to Marketing Approval for Alzheimers' Disease Program